<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jkto</journal-id><journal-title-group><journal-title xml:lang="ru">Кафедра травматологии и ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Department of Traumatology and Orthopaedics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-2016</issn><publisher><publisher-name>ПРОФИЛЬ — 2С</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10/17238/issn2226-2016.2026.1.39-46</article-id><article-id custom-type="elpub" pub-id-type="custom">jkto-124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Перспективы использования хелатной формы цинка с гиалуронаном в качестве сеноморфика, модифицирующего анаболические функции сенесцентных хондроцитов</article-title><trans-title-group xml:lang="en"><trans-title>Prospects of using a chelated form of zinc with hyaluronan as a cenomorphic modifying the anabolic functions of senescent chondrocytes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хабаров</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Khabarov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Николаевич Хабаров, к. х. н., генеральный директор АНО</p><p>АНО «Научно-исследовательский центр гиалуроновой кислоты»</p><p>119146; Комсомольский пр., 16/38; Москва</p></bio><bio xml:lang="en"><p>Vladimir N. Khabarov, Candidate of Chemical Sciences, General Director at the Center</p><p>Scientific Research Center of Hyaluronic Acid</p><p>119146; 8/16 Komsomolsky Ave.; Moscow</p></bio><email xlink:type="simple">info@nicgk.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беляевский</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyaevsky</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валентин Александрович Беляевский, врач по спортивной медицине, травматолог-ортопед</p><p>117418; Новочеремушкинская 50 к2; Москва</p></bio><bio xml:lang="en"><p>Valentin A. Belyaevsky, sports medicine doctor, orthopedic traumatologist</p><p>117418; Novocheremushkinskaya 50 k 2; Moscow</p></bio><email xlink:type="simple">v.belyayevskiy@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский центр гиалуроновой кислоты</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Research Center of Hyaluronic Acid</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Частная клиника «Биони Медикал»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Private clinic "Bioni Medical"</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2026</year></pub-date><volume>0</volume><issue>1</issue><fpage>39</fpage><lpage>46</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хабаров В.Н., Беляевский В.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Хабаров В.Н., Беляевский В.А.</copyright-holder><copyright-holder xml:lang="en">Khabarov V.N., Belyaevsky V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jkto.moscow/jour/article/view/124">https://www.jkto.moscow/jour/article/view/124</self-uri><abstract><sec><title>   Обоснование</title><p>   Обоснование. Поиск веществ и методов, замедляющих и/или предотвращающих процессы разрушения хряща суставов, актуален в медицине. Известно, что ингибирование экспрессии генов основных белковых комплексов – аггрекана и декорина способствует егоразрушению.</p></sec><sec><title>   Цель исследования</title><p>   Цель исследования: изучить влияние протеза синовиальной жидкости с хелатной формой цинка и гиалуроновой кислотой на экспрессиюаггрекана, декорина и трансформирующего фактора роста (TGF-β1) в культуре сенесцентных хондроцитов.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы: источником первичной культуры хондроцитов являлась реберная хрящевая ткань. Для моделирования инфламэйджинга генотоксического стресса на культуру клеток воздействовали ультрафиолетом. Изучали четыре типа культур хондроцитов: контрольная – нормальная культура (2–4 пассаж с добавлением ростовой среды); культура с моделью инфламэйджинга (МИ); культура с комбинацией инфламэйджинг + гиалуроновый гель (МИ + ГК); культура с комбинацией инфламэйджинг + препарат «Ювента» с хелатом цинка (МИ + Ювента). Верификация белковых факторов проводилась методом иммуноцитохимии с использованием первичных моноклональных антител коллагена II, IV типов. Для визуализации использовали иммунофлуоресцентную конфокальную микроскопию. Разницу в экспрессии исследуемых маркеров наблюдали в зависимости от интенсивности свечения красителей.</p></sec><sec><title>   Результаты</title><p>   Результаты: При развитии у клеток SASP-фенотипа экспрессия аггрекана снизилась в 5,6 раза по сравнению с контрольной и составила 0,60 %. Введение ГК повышало экспрессию аггрекана до 1,34 %, а «ЮВЕНТА» - до 5,88 %. Экспрессия TGF-β1 снизилась до 0,12 %. Введение ГК и «ЮВЕНТА» привело к равному увеличению уровня экспрессии TGF- β1: 1,47 % и 1,45 %, соответственно. Экспрессия декорина снизилась более, чем в 16 раз, значительного влияния «ЮВЕНТЫ» по сравнению с чистого ГК обнаружено не было.</p></sec><sec><title>   Заключение</title><p>   Заключение: Протез синовиальной жидкости на основе гиалуроновой кислоты с хелатной формой цинка способен частично восстанавливать анаболическую активность сенесцентных хондроцитов путем повышения экспрессии компонентов хрящевого матрикса, прежде всего, аггрекана.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Introduction</title><p>   Introduction. Strategies that can slow or prevent articular cartilage deterioration remain clinically important. Reduced expression of genes encoding major extracellular matrix components, including aggrecan and decorin, is associated with cartilage degeneration.</p></sec><sec><title>   Objective</title><p>   Objective: To assess how a hyaluronic-acid–based synovial fluid substitute containing chelated zinc influences the expression of aggrecan, decorin, and transforming growth factor TGF-β1 in a senescent chondrocyte model.</p></sec><sec><title>   Methods</title><p>   Methods: Primary chondrocytes were isolated from costal cartilage and cultured. Cellular senescence/inflammaging-associated genotoxic stress was induced by ultraviolet irradiation. Four conditions were compared: (1) untreated control culture; (2) inflammaging model (IM); (3) IM with hyaluronic acid gel (IM+HA); and (4) IM with the hyaluronic acid + chelated zinc preparation Yuventa (IM+Yuventa). Chondrocyte phenotype was confirmed by immunocytochemistry using monoclonal antibodies to type II and type IV collagen, with signal detection by confocal immunofluorescence microscopy. Relative expression of target markers was evaluated from fluorescence intensity.</p></sec><sec><title>   Results</title><p>   Results: IM was accompanied by a pronounced decline in aggrecan expression (5.6-fold vs control; 0.60 %). HA partially increased aggrecan to 1.34 %, whereas Yuventa raised it to 5.88 %. TGF-β1 dropped to 0.12 % under IM and increased comparably with HA and Yuventa (1.47 % and 1.45 %, respectively). Decorin decreased more than 16-fold under IM; Yuventa did not demonstrate a clear advantage over HA alone for this marker.</p></sec><sec><title>   Conclusion</title><p>   Conclusion: Hyaluronic acid supplemented with chelated zinc may partially restore anabolic activity in senescent chondrocytes, primarily by enhancing aggrecan expression.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>аггрекан</kwd><kwd>декорин</kwd><kwd>трансформирующий фактор роста</kwd><kwd>хелат цинка с гилуронаном</kwd><kwd>остеоартрит</kwd><kwd>SASP-фенотип хондроцитов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>aggrecan</kwd><kwd>decorin</kwd><kwd>transforming growth factor</kwd><kwd>zinc chelate with giluronan</kwd><kwd>osteoarthritis</kwd><kwd>SASP-phenotype of chondrocytes</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study had no sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Хабаров В.Н., Беляевский В.А. Молекулярно-клеточные механизмы инициирования и прогрессирования суставных патологий (Обзор литературы). Кафедра травматологии и ортопедии. 2025;(4): 138-147. DOI: 10.17238/issn2226-2016.2025.4.146-156.</mixed-citation><mixed-citation xml:lang="en">Khabarov V.N., Belyaevsky V.A. Molecular and cellular mechanisms of initiation and progression of joint pathologies (Literature review). Department of Traumatology and Orthopedics. 2025;(4): 138-147. DOI: 10.17238/issn2226-2016.2025.4.146-156</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S., Yang J., Xiang R., et al. Research and publication trends on knee osteoarthritis and cellular senescence: a bibliometric analysis. Front Physiol. 2023;14:1269-338. DOI: 10.3389/fphys.2023.1269338.</mixed-citation><mixed-citation xml:lang="en">Wang S., Yang J., Xiang R., et al. Research and publication trends on knee osteoarthritis and cellular senescence: a bibliometric analysis. Front Physiol. 2023;14:1269-338. DOI: 10.3389/fphys.2023.1269338.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y., Zhang Z., Li T., et al. Senescence in osteoarthritis: from mechanism to potential treatment. Arthritis Res Ther. 2022; 24(1):174. DOI: 10.1186/s13075-022-02859-x.</mixed-citation><mixed-citation xml:lang="en">Liu Y., Zhang Z., Li T., et al. Senescence in osteoarthritis: from mechanism to potential treatment. Arthritis Res Ther. 2022; 24(1):174. DOI: 10.1186/s13075-022-02859-x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Хабаров В.Н., Миронова Е.С. Инфламэйджинг: роль сенесцентных хондроцитов в патогенезе ОА. Успехи геронтологии. 2024;37(6):777-86. DOI: 10.34922/AE.2024.37.6.013.</mixed-citation><mixed-citation xml:lang="en">Khabarov V.N., Mironova E.S. Inflamaging: the role of senescent chondrocytes in the pathogenesis of OA. Advances in Gerontology. 2024;37(6):777–86. DOI: 10.34922/AE.2024.37.6.013</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Oliviero F, Ramonda R. Cartilage-derived biomarkers in osteoarthritis. Indian J Med Res. 2021;153(4):413-15. DOI: 10.4103/ijmr.IJMR_436_20.</mixed-citation><mixed-citation xml:lang="en">Oliviero F, Ramonda R. Cartilage-derived biomarkers in osteoarthritis. Indian J Med Res. 2021;153(4):413-15. DOI: 10.4103/ijmr.IJMR_436_20.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Moretti L, Bizzoca D, Geronimo A, Moretti F, Monaco E, Solarino G, Moretti B. Towards Precision Medicine for Osteoarthritis: Focus on the Synovial Fluid Proteome. Int J Mol Sci. 2022; 23(17):9731. DOI: 10.3390/ijms23179731.</mixed-citation><mixed-citation xml:lang="en">Moretti L, Bizzoca D, Geronimo A, Moretti F, Monaco E, Solarino G, Moretti B. Towards Precision Medicine for Osteoarthritis: Focus on the Synovial Fluid Proteome. Int J Mol Sci. 2022; 23(17):9731. DOI: 10.3390/ijms23179731.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wu L, Wen D, Wang W, Wang Y, Zhang L. Identification of key genes in osteoarthritis development: biomarker discovery and therapeutic targets. Front Med (Lausanne). 2025; 12:1518-580. DOI: 10.3389/fmed.2025.1518580.</mixed-citation><mixed-citation xml:lang="en">Wu L, Wen D, Wang W, Wang Y, Zhang L. Identification of key genes in osteoarthritis development: biomarker discovery and therapeutic targets. Front Med (Lausanne). 2025; 12:1518-580. DOI: 10.3389/fmed.2025.1518580.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Alcaide-Ruggiero L, Cugat R, Domínguez J. Proteoglycans in Articular Cartilage and Their Contribution to Chondral Injury and Repair Mechanisms. Int J Mol Sci. 2023; 24(13):10824. DOI: 10.3390/ijms241310824.</mixed-citation><mixed-citation xml:lang="en">Alcaide-Ruggiero L, Cugat R, Domínguez J. Proteoglycans in Articular Cartilage and Their Contribution to Chondral Injury and Repair Mechanisms. Int J Mol Sci. 2023; 24(13):10824. DOI: 10.3390/ijms241310824.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Li Q, Han B, Wang C, Tong W, Wei Y, Tseng W, Han L, Liu X, Enomoto-Iwamoto M, Mauck L, Qin L, Iozzo R, Birk D, Han L. Mediation of Cartilage Matrix Degeneration and Fibrillation by Decorin in Post-traumatic Osteoarthritis. Arthritis Rheumatol. 2020; 72(8):1266-77. DOI: 10.1002/art.41254.</mixed-citation><mixed-citation xml:lang="en">Li Q, Han B, Wang C, Tong W, Wei Y, Tseng W, Han L, Liu X, Enomoto-Iwamoto M, Mauck L, Qin L, Iozzo R, Birk D, Han L. Mediation of Cartilage Matrix Degeneration and Fibrillation by Decorin in Post-traumatic Osteoarthritis. Arthritis Rheumatol. 2020; 72(8):1266-77. DOI: 10.1002/art.41254.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang M, Li Z, Zhang M, Wang H, Zhang Y. Decorin knockdown affects the gene expression profile of adhesion, growth and extracellular matrix metabolism in C-28/I2 chondrocytes. PLoS One. 2020; 15(4):0232-321. DOI: 10.1371/journal.pone.0232321.</mixed-citation><mixed-citation xml:lang="en">Wang M, Li Z, Zhang M, Wang H, Zhang Y. Decorin knockdown affects the gene expression profile of adhesion, growth and extracellular matrix metabolism in C-28/I2 chondrocytes. PLoS One. 2020; 15(4):0232-321. DOI: 10.1371/journal.pone.0232321.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов П.Л., Хабаров В.Н. Твердофазный способ получения биоактивной композиции на основе хелатных комплексов цинка, магния, марганца, меди и хрома с гиалуроновой кислотой. Патент РФ № 2780485, 2022.</mixed-citation><mixed-citation xml:lang="en">Ivanov P.L., Khabarov V.N. Solid-phase method for producing a bioactive composition based on chelate complexes of zinc, magnesium, manganese, copper, and chromium with hyaluronic acid. Russian Federation Patent No. 2780485, 2022</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов П.Л., Хабаров В.Н. Протез синовиальной жидкости и способ его получения. Патент РФ №2782921, 2022.</mixed-citation><mixed-citation xml:lang="en">Ivanov P.L., Khabarov V.N. Synovial fluid prosthesis and method for producing it. Russian Federation Patent No. 2782921, 2022</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kurakazu I, Akasaki Y, Tsushima H, et al. TGFβ1 signaling protects chondrocytes against oxidative stress via FOXO1-autophagy axis. Osteoarthritis Cartilage. 2021;29(11):1600-1613. DOI: 10.1016/j.joca.2021.07.015.</mixed-citation><mixed-citation xml:lang="en">Kurakazu I, Akasaki Y, Tsushima H, et al. TGFβ1 signaling protects chondrocytes against oxidative stress via FOXO1-autophagy axis. Osteoarthritis Cartilage. 2021;29(11):1600-1613. DOI: 10.1016/j.joca.2021.07.015.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lei Z, Tang R, Wu Y, et al. TGF-beta1 induces PD-1 expression in macrophages through SMAD3/STAT3 cooperative signaling in chronic inflammation. JCI Insight. 2024;9(7):1655-44. DOI: 10.1172/jci.insight.165544.</mixed-citation><mixed-citation xml:lang="en">Lei Z, Tang R, Wu Y, et al. TGF-beta1 induces PD-1 expression in macrophages through SMAD3/STAT3 cooperative signaling in chronic inflammation. JCI Insight. 2024;9(7):1655-44. DOI: 10.1172/jci.insight.165544.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Schroeder R, De Jesus MA, Saweikis S, et al. Novel Interleukin-11 Inhibitors Attenuate Collagen Production in Patient-Derived Synovial Fibroblasts. Cureus. 2025;17(8):898-50. DOI: 10.7759/cureus.89850.</mixed-citation><mixed-citation xml:lang="en">Schroeder R, De Jesus MA, Saweikis S, et al. Novel Interleukin-11 Inhibitors Attenuate Collagen Production in Patient-Derived Synovial Fibroblasts. Cureus. 2025;17(8):898-50. DOI: 10.7759/cureus.89850.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ishizuka S, Tsuchiya S, Ohashi Y, et al. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan. J Biol Chem. 2019; 294(37):13562-79. DOI: 10.1074/jbc.RA119.008567.</mixed-citation><mixed-citation xml:lang="en">Ishizuka S, Tsuchiya S, Ohashi Y, et al. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan. J Biol Chem. 2019; 294(37):13562-79. DOI: 10.1074/jbc.RA119.008567.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Хабаров В.Н., Бойков П.Я., Колосов В.А., Иванов П.Л. Гиалуронан в артрологии. М. Эдвантедж сольюшин. 2014. ISBN 978-5-906722-14-0.</mixed-citation><mixed-citation xml:lang="en">Khabarov V.N., Boykov P.Ya., Kolosov V.A., Ivanov P.L. Hyaluronan in arthrology. M. Advantage Solyushin. 2014. ISBN 978-5-906722-14-0.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez S, Moura H, Chow E, Kuo J, Paszek M, Bonassar L. Recombinant Small Leucine-Rich Proteoglycans Modulate Fiber Structure and Mechanical Properties of Collagen Gels. ACS Biomater Sci Eng. 2025; 11(7):4101-15. DOI: 10.1021/acsbiomaterials.5c00732.</mixed-citation><mixed-citation xml:lang="en">Lopez S, Moura H, Chow E, Kuo J, Paszek M, Bonassar L. Recombinant Small Leucine-Rich Proteoglycans Modulate Fiber Structure and Mechanical Properties of Collagen Gels. ACS Biomater Sci Eng. 2025; 11(7):4101-15. DOI: 10.1021/acsbiomaterials.5c00732.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Baghy K, Szakadáti H, Kovalszky I. Decorin the antifibrotic proteoglycan and its progression in therapy. Am J Physiol Cell Physiol. 2025; 328(6):1853-65. DOI: 10.1152/ajpcell.01075.2024.</mixed-citation><mixed-citation xml:lang="en">Baghy K, Szakadáti H, Kovalszky I. Decorin the antifibrotic proteoglycan and its progression in therapy. Am J Physiol Cell Physiol. 2025; 328(6):1853-65. DOI: 10.1152/ajpcell.01075.2024.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
